Mark T Iwicki insider trades
Open-market stock purchases and sales by Mark T Iwicki, Unknown at Q32 Bio Inc, from SEC Form 4 filings since Aug 11, 2015.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 12, 2026 | QTTB Q32 Bio Inc | Bought (not open market) | — |
| Jan 5, 2026 | IKT Inhibikase Therapeutics, Inc | Bought (not open market) | — |
| Dec 12, 2025 | MRUS Merus NV | Sold (not open market) | — |
| Dec 12, 2025 | MRUS Merus NV | Sold (not open market) | — |
| Dec 12, 2025 | MRUS Merus NV | Sold (not open market) | — |
| Dec 12, 2025 | MRUS Merus NV | Sold (not open market) | $7.1M |
| Dec 12, 2025 | MRUS Merus NV | Sold (not open market) | — |
| Dec 12, 2025 | MRUS Merus NV | Sold (not open market) | — |
| Dec 12, 2025 | MRUS Merus NV | Sold (not open market) | — |
| Dec 12, 2025 | MRUS Merus NV | Sold (not open market) | — |
| Dec 12, 2025 | MRUS Merus NV | Sold (not open market) | — |
| Dec 12, 2025 | MRUS Merus NV | Sold (not open market) | — |
| Dec 9, 2025 | AKRO Akero Therapeutics, Inc | Sold (not open market) | — |
| Dec 9, 2025 | AKRO Akero Therapeutics, Inc | Sold (not open market) | $599K |
| Dec 9, 2025 | AKRO Akero Therapeutics, Inc | Sold (not open market) | $122K |
| Dec 9, 2025 | AKRO Akero Therapeutics, Inc | Sold (not open market) | $328K |
| Dec 9, 2025 | AKRO Akero Therapeutics, Inc | Sold (not open market) | $495K |
| Dec 9, 2025 | AKRO Akero Therapeutics, Inc | Sold (not open market) | $73.1K |
| Dec 9, 2025 | AKRO Akero Therapeutics, Inc | Sold (not open market) | $46.9K |
| Oct 23, 2025 | KALA KALA BIO, Inc | Sold | $125K |
| Oct 23, 2025 | QTTB Q32 Bio Inc | Bought (not open market) | — |
Companies traded
- QTTB Q32 Bio Inc: other filings, last Jun 12, 2026
- IKT Inhibikase Therapeutics, Inc: other filings, last Jan 5, 2026
- MRUS Merus NV: other filings, last Dec 12, 2025
- AKRO Akero Therapeutics, Inc: other filings, last Dec 9, 2025
- KALA KALA BIO, Inc: 14 sales, last Oct 23, 2025
- THRD Third Harmonic Bio, Inc: other filings, last Aug 11, 2025
- AVTE Aerovate Therapeutics, Inc: other filings, last Jun 5, 2024
- PULM Pulmatrix, Inc: 1 buy, last Jan 28, 2021
- AIMT Aimmune Therapeutics, Inc: 2 buys, last Oct 13, 2020